Abstract
Purpose
In breast cancer patients treated in the 1970s and 1980s, radiation therapy (RT) for left-sided tumors has been associated with an elevated risk of cardiac mortality. In recent years, improved RT techniques have reduced radiation exposure of the heart and major coronary vessels, but some exposure remains unavoidable. In a retrospective cohort study, we investigated the long-term cardiac mortality risk of breast cancer survivors treated with modern RT in Germany.
Methods
A total of 11,982 women were included who were treated for breast cancer between 1998 and 2008. A systematic mortality follow-up was conducted until December 2012. The effect of breast cancer laterality on cardiac mortality and on overall mortality was investigated as a surrogate measure of exposure. Using Cox regression, we analyzed survival time as the primary outcome measure, taking potential confounding factors into account.
Results
We found no evidence for an effect of tumor laterality on mortality in irradiated patients (N = 9058). For cardiac mortality, the hazard ratio was 0.94 (95% CI 0.64–1.38) for left-sided versus right-sided tumors. For all causes of death, the hazard ratio was 0.95 (95% CI 0.85–1.05). A diagnosis of cardiac illness prior to breast cancer treatment increased both cardiac mortality risk and overall mortality risk.
Conclusions
Contemporary RT seems not to be associated with an increased risk of cardiac mortality or overall mortality for left-sided breast cancer relative to right-sided RT. However, an extended follow-up period and exact dosimetry might be necessary to confirm this observation.
Similar content being viewed by others
Abbreviations
- CIS:
-
Carcinoma in situ
- CI:
-
Confidence interval
- HR:
-
Hazard ratio
- ICD:
-
International classification of diseases
- PY:
-
Person-years
- RT:
-
Radiotherapy
References
International Agency for Research on Cancer (2014) Cancer in five continents, Vol X, IARC Scientific Publications No. 164. Lyon
Robert-Koch-Institut und GEKID (2015) Krebs in Deutschland 2011/2012. Berlin
Schwentner L, Wöckel A, König J, Janni W, Ebner F, Blettner M, Kreienberg R, Van Ewijk R (2013) Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients. BMC Cancer 13:487–499
Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD (2014) Second malignant neoplasms and cardiovascular disease following radiotherapy. Health Phys 106(2):229–246
Borghini A, Gianicolo EAL, Picano E, Andreassi MG (2013) Ionizing radiation and atherosclerosis: current knowledge and future challenges. Atherosclerosis 230:40–47
Steward FA, Hoving S, Russell NS (2010) Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res 174:865–869
Early Breast Cancer Trialists´ Collaborative Group (2000) Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 355:1757–1770
Early Breast Cancer Trialists´ Collaborative Group (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 366:2087–2106
Darby SC, McGale P, Taylor CW, Peto R (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557–565
Darby S, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 11:987–998
Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E et al (2015) Primary breast cancer: eSMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(supplement 5):8–30
Thariat J, Hannoun-Levi JM, Sun Myint A, Vuong T, Gérard JP (2012) Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol 10:52–60
Taylor CW, Wang Z, Macaulay E, Jagsi R, Duane F, Darby SC (2015) Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003 to 2013. Int J Radiat Oncol Biol Phys 93:845–853
Killander F, Anderson H, Kjellen E, Malmström P (2014) Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy—25 year follow-up of a randomized trial from the South Sweden Breast cancer Group. European J Cancer 50:2201–2210
Wollschläger D, Karle H, Stockinger M, Bartkowiak D, Buhrdel S, Merzenich H, Wiegel T, Blettner M, Schmidberger H (2016) Radiation dose distribution in functional heart regions from tangential breast cancer radiotherapy. Radiother Oncol 119:65–70
Wollschläger D, Karle H, Stockinger M, Bartkowiak D, Buhrdel S, Merzenich H, Wiegel T, Schmidberger H, Blettner M (2016) Predicting heart dose in breast cancer patients who received 3D conformal radiation therapy. Health Phys 119:65–70
Cox DR, Oakes D (1984) Analysis of survival data. Chapman and Hall, New York
Core Team R (2016) A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer, New York
American Joint Committee on Cancer (2010) AJCC cancer staging handbook, 7th edn. Springer, New York
Robert-Koch-Institut (2010) GEDA-Survey „Gesundheit in Deutschland 2010“. Gesundheitsberichterstattung des Bundes, Berlin
Henson KE, McGale P, Taylor C, Darby SC (2013) Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer 108:179–182
McGale P, Darby SC, Hall P, Adolfson J, Bengtsson NO, Bennet AM, Fornander T, Gigante B, Jensen MB, Peto R, Rahimi K, Taylor WT, Ewertz M (2011) Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 100(2):167–175
Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, Yashar CM, Moiseenko V, Einck JP, Mell LK, Parikh SA, Murphy JD (2015) Modern radiation therapy and cardiac outcomes in breast cancer. Int J Radiation Oncol Biol Phys 94(4):700–708
Rutter CE, Chagpar AB, Evans SB (2014) Breast cancer laterality does not influence survival in a large modern cohort: implications for radiation-related cardiac mortality. Int J Radiation Oncol Biol Phys 90(2):329–334
Bouchardy C, Rapiti E, Usel M, Balmer Majno S, Vlastos G, Benhamou S, Mirabell R, Neyroud-Caspar I, Verkooijen HM, Vinh-Hung V (2010) Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors. Ann Oncol 21:459–465
Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR (2012) Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors. Cancer 118(8 suppl):2270–2276
Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PW, Wolf PA, Levy D (2006) Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113:791–798
Rothman KJ (1986) Modern Epidemiology. Little,Brown & Company, Boston/Toronto
Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Moller H (2007) Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer A population based study. BMC Cancer 7:9
Darby SC, McGale P, Granath F Peto R, Hall P, Ekbom A (2003) Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90,000 Swedish women. BMJ 326:256–257
Schubert-Fritschle G, Eckel R, Eisenmenger W, Hölzel D (2002) Qualität der Angaben von Todesbescheinigungen. Dt. Ärzteblatt 99(1–2):C36–C41
Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165(6):710–718
Acknowledgements
This work was supported by the German Federal Ministry of Education and Research (BMBF) with Contract No. (02NUK026B). The study sponsor had no involvement in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, or in the decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Merzenich, H., Bartkowiak, D., Schmidberger, H. et al. 3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study). Breast Cancer Res Treat 161, 143–152 (2017). https://doi.org/10.1007/s10549-016-4042-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-016-4042-2